Prolifagen, Inc. — Form D

Prolifagen, Inc. of DOYLESTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-23. $3.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-09-23
• Form: D
• Accession: 0002086999-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Amount sold: $3.0M
• Investors: 6
• Date of first sale: 2025-09-02
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-558335

Issuer

• Name: Prolifagen, Inc.
• CIK: 0002086999
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
• Phone: 610-656-5229

Officers, directors & promoters (7)

More

• CIK 2086999 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search